Significant correlation between ctDNA levels and tumor burden in anti-PD1-treated patients with various cancersSignificant correlation between ctDNA and tumor burden in HCC patients treated with atezolizumab plus bevacizumab. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.